This is just part of the conclusions from the full PDF
Well that's more medications easily avoided by LC/HF, but of course LowCarb is unsafe best follow the high carb dietary guidelines for the benefits far outweigh the effects of toxic drugs
To date, the literature provides little information on the potential mechanism that could underlie the muscular toxicity of DPP-4 inhibitors. It is suggested that these drugs may have pleiotropic effects and be implicated in lipid synthesis (9,10); if so, the mechanism could involve the cholesterol synthesis pathway, similar to that suspected for statins or fibrates.
This study confirms a potential muscular toxicity of DPP-4 inhibitors and advocates for pharmacoepidemiological studies to be conducted in order to further explore this potential risk. Meanwhile, physicians and patients should remain vigilant concerning this putative risk, regardless of whether DPP-4 inhibitors are used in combination with statins.
http://care.diabetesjournals.org/content/diacare/early/2016/12/19/dc16-1822.full.pdf
Well that's more medications easily avoided by LC/HF, but of course LowCarb is unsafe best follow the high carb dietary guidelines for the benefits far outweigh the effects of toxic drugs